Showing results (861-870 of 1,044) with videos related to
Sort By:
Pageof 105
Leukemia|January 7, 2026
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human studyNoffar Bar, Thomas Martin, Craig C Hofmeister, et al.Maturitas|July 18, 2021
Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statementMargaret Rees, Johannes Bitzer, Antonio Cano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
Neratinib-Plus-Cetuximab in Quadruple-WT (<i>KRAS, NRAS, BRAF, PIK3CA</i>) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib StudySamuel A Jacobs, James J Lee, Thomas J George, et al.Radiology. Artificial Intelligence|May 3, 2021
Robust Deep Learning-based Segmentation of Glioblastoma on Routine Clinical MRI Scans Using Sparsified TrainingRoelant S Eijgelaar, Martin Visser, Domenique M J Müller, et al.British Journal of Clinical Pharmacology|July 5, 2019
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunctionNaoko Takebe, Jan H Beumer, Shivaani Kummar, et al.Neuro-Oncology|August 26, 2025
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET - a retrospective, bicentric cohort studyMaximilian J Mair, Jan-Michael Werner, Jonathan Weller, et al.Global Change Biology. Bioenergy|March 20, 2024
Novel Miscanthus hybrids: Modelling productivity on marginal land in Europe using dynamics of canopy development determined by light interceptionAnita Shepherd, Danny Awty-Carroll, Jason Kam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2020
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma SubgroupChristine Pirker, Agnes Bilecz, Michael Grusch, et al.Cancer|March 13, 2026
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)Aarti Bhatia, Zhengjia Chen, Yuji Zhang, et al.Acta Neuropathologica Communications|April 28, 2022
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasivenessLisa Gabler, Carola Nadine Jaunecker, Sonja Katz, et al.Pageof 105